Antimalarial drugs: modes of action and mechanisms of parasite resistance.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Future Microbiology

• Publication date

  2010-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/fmb.10.136PMID 21155666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

  2012cited by this paper
• Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations

  2010cited by this paper
• DMSO triggers the generation of ROS leading to an increase in artemisinin and dihydroartemisinic acid in Artemisia annua shoot cultures

  2010cited by this paper
• The pharmaceutical death-ride of dihydroartemisinin

  2010cited by this paper
• What made sesquiterpene lactones reach cancer clinical trials?

  2010cited by this paper
• Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum.

  2010cited by this paper
• In Vitro Sensitivity of Plasmodium falciparum Clinical Isolates from the China-Myanmar Border Area to Quinine and Association with Polymorphism in the Na+/H+ Exchanger

  2010cited by this paper
• The Molecular Mechanism of Action of Artemisinin—The Debate Continues

  2010cited by this paper
• Identification of a Mutant PfCRT-Mediated Chloroquine Tolerance Phenotype in Plasmodium falciparum

  2010cited by this paper
• Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.

  2010cited by this paper
• Thousands of chemical starting points for antimalarial lead identification

  2010cited by this paper
• Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.

  2010cited by this paper
• Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally.

  2010cited by this paper
• The RTS,S malaria vaccine.

  2010cited by this paper
• Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum

  2010cited by this paper
• Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus.

  2010cited by this paper
• Chemical genetics of Plasmodium falciparum

  2010cited by this paper
• Drug discovery: Priming the antimalarial pipeline

  2010cited by this paper
• In Vitro Activities of Quinine and Other Antimalarials and pfnhe Polymorphisms in Plasmodium Isolates from Kenya

  2010cited by this paper
• Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum

  2010cited by this paper
• Amodiaquine Resistance in Plasmodium falciparum Malaria in Afghanistan Is Associated with the pfcrt SVMNT Allele at Codons 72 to 76

  2010cited by this paper
• Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.

  2010cited by this paper
• Role of medicines in malaria control and elimination

  2010influential reference
• Investigations into the Role of the Plasmodium falciparum SERCA (PfATP6) L263E Mutation in Artemisinin Action and Resistance

  2010cited by this paper
• Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs

  2010cited by this paper
• Hematin-hematin self-association states involved in the formation and reactivity of the malaria parasite pigment, hemozoin.

  2010cited by this paper
• Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue.

  2010cited by this paper
• High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.

  2010cited by this paper
• The ABCs of multidrug resistance in malaria.

  2010cited by this paper
• Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009

  2010cited by this paper
• Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation

  2010cited by this paper
• Shape‐ and Chemical Feature‐Based 3D‐Pharmacophore Model Generation and Virtual Screening: Identification of Potential Leads for P. falciparum DHFR Enzyme Inhibition

  2010cited by this paper
• Malaria: what can apes teach humans?

  2010cited by this paper
• In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation

  2009cited by this paper
• Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione

  2009cited by this paper
• In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.

  2009cited by this paper
• Existing antimalarial agents and malaria-treatment strategies

  2009cited by this paper
• Molecular Correlates of High-Level Antifolate Resistance in Rwandan Children with Plasmodium falciparum Malaria

  2009cited by this paper
• Polymorphism in PfMRP1 (Plasmodium falciparum Multidrug Resistance Protein 1) Amino Acid 1466 Associated with Resistance to Sulfadoxine-Pyrimethamine Treatment

  2009cited by this paper
• Chloroquine Transport via the Malaria Parasite’s Chloroquine Resistance Transporter

  2009cited by this paper
• Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa.

  2009cited by this paper
• Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.

  2009cited by this paper
• Artemisinin resistance on the Thai-Cambodian border.

  2009cited by this paper
• Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum

  2009cited by this paper
• Artemisinin resistance on the Thai-Cambodian border.

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• The myth of the virgin rape myth – Authors' reply

  2009cited by this paper
• Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.

  2009cited by this paper
• Multiple Origins and Regional Dispersal of Resistant dhps in African Plasmodium falciparum Malaria

  2009cited by this paper
• Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane

  2009cited by this paper
• Countries race to contain resistance to key antimalarial.

  2009cited by this paper
• Chloroquine resistance before and after its withdrawal in Kenya

  2009cited by this paper
• Chloroquine transport in Plasmodium falciparum. 2. Analysis of PfCRT-mediated drug transport using proteoliposomes and a fluorescent chloroquine probe.

  2009cited by this paper
• INAUGURAL ARTICLE by a Recently Elected Academy Member:Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine

  2009cited by this paper
• Reduced digestive vacuolar accumulation of chloroquine is not linked to resistance to chloroquine toxicity.

  2009cited by this paper
• A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria

  2009cited by this paper
• Discovery, mechanisms of action and combination therapy of artemisinin

  2009cited by this paper
• Hybrid drugs for malaria.

  2009cited by this paper
• Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE.

  2009cited by this paper
• Novel pfdhps Haplotypes among Imported Cases of Plasmodium falciparum Malaria in the United Kingdom

  2009cited by this paper
• Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

  2009cited by this paper
• Stepwise acquisition of pyrimethamine resistance in the malaria parasite

  2009cited by this paper
• Resistance to antimalarial compounds: methods and applications.

  2009cited by this paper
• Chloroquine transport in Plasmodium falciparum. 1. Influx and efflux kinetics for live trophozoite parasites using a novel fluorescent chloroquine probe.

  2009cited by this paper
• Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria

  2009cited by this paper
• Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand.

  2009cited by this paper
• Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.

  2009cited by this paper
• The Global Portfolio of New Antimalarial Medicines Under Development

  2009cited by this paper
• The development of the RTS,S malaria vaccine candidate: challenges and lessons

  2009cited by this paper
• Plasmodium falciparum Na+/H+ Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine

  2009cited by this paper
• Adaptive Copy Number Evolution in Malaria Parasites

  2008cited by this paper
• Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria.

  2008cited by this paper
• Polymorphisms within PfMDR1 alter the substrate specificity for anti‐malarial drugs in Plasmodium falciparum

  2008cited by this paper
• Evidence of artemisinin-resistant malaria in western Cambodia.

  2008cited by this paper
• Antifolate resistance in Africa and the 164-dollar question.

  2008cited by this paper
• Qinghaosu (Artemisinin): The Price of Success

  2008cited by this paper
• Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia

  2008cited by this paper
• Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.

  2008cited by this paper
• Revising antimalarial drug policy in Central America: experience in Panama.

  2008cited by this paper
• Chloroquine Resistance-Conferring Mutations in pfcrt Give Rise to a Chloroquine-Associated H+ Leak from the Malaria Parasite's Digestive Vacuole

  2008cited by this paper
• Genome-Wide Compensatory Changes Accompany Drug- Selected Mutations in the Plasmodium falciparum crt Gene

  2008cited by this paper
• Drug resistance and genetic mapping in Plasmodium falciparum

  2008cited by this paper
• Plasmodium knowlesi: the fifth human malaria parasite.

  2008cited by this paper
• Inhibition of efflux of quinolines as new therapeutic strategy in malaria.

  2008cited by this paper
• Discordant Patterns of Genetic Variation at Two Chloroquine Resistance Loci in Worldwide Populations of the Malaria Parasite Plasmodium falciparum

  2008cited by this paper
• Dissecting the components of quinine accumulation in Plasmodium falciparum

  2008cited by this paper
• Malaria: progress, perils, and prospects for eradication.

  2008cited by this paper
• Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil

  2008cited by this paper
• Plasmodium falciparum Strains Harboring Dihydrofolate Reductase with the I164L Mutation Are Absent in Malawi and Zambia Even under Antifolate Drug Pressure

  2008cited by this paper
• Open Access Research

  2007cited by this paper
• Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.

  2007cited by this paper
• Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum

  2007cited by this paper
• Drug‐resistant malaria − an insight

  2007cited by this paper
• A novel artemisinin-quinine hybrid with potent antimalarial activity.

  2007cited by this paper
• Conflicting Requirements of Plasmodium falciparum Dihydrofolate Reductase Mutations Conferring Resistance to Pyrimethamine-WR99210 Combination

  2007cited by this paper
• Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand.

  2007cited by this paper
• Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine

  2007cited by this paper
• Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.

  2007cited by this paper
• Quantitative pH measurements in Plasmodium falciparum‐infected erythrocytes using pHluorin

  2007cited by this paper
• Common Origin and Fixation of Plasmodium falciparum dhfr and dhps Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in a Low-Transmission Area in South America

  2007cited by this paper

• In-silico identification of sulfur and selenium analogous to artemisinin as potential antimalarial drug candidates

  2025cites this paper
• Emerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success.

  2025cites this paper
• Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment

  2025cites this paper
• Reverse N-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR).

  2024cites this paper
• PfHDAC1 is an essential regulator of P. falciparum asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress

  2024cites this paper
• Genomic analysis of Indian isolates of Plasmodium falciparum: Implications for drug resistance and virulence factors

  2023cites this paper
• Current advances in nanodrug delivery systems for malaria prevention and treatment

  2023cites this paper
• A conserved metabolic signature associated with response to fast-acting anti-malarial agents

  2023cites this paper
• From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?

  2023cites this paper
• Roles of Virtual Screening and Molecular Dynamics Simulations in Discovering and Understanding Antimalarial Drugs

  2023cites this paper
• Molecular structure, spectral, computational, IEFPCM investigation, and topological study on the biologically potent; cardiotonic drug 2-Chloroquinolin-3-amine with structural optimization

  2023cites this paper
• A conserved metabolic signature associated with response to fast-acting antimalarial agents

  2022cites this paper
• PfHDAC1 is an essential regulator of parasite asexual growth with its altered genomic occupancy and activity associated with artemisinin drug resistance in Plasmodium falciparum

  2022cites this paper
• Identification of promising inhibitors for Plasmodium haemoglobinase Falcipain-2, using virtual screening, molecular docking, and MD Simulation

  2022cites this paper
• Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy

  2022cites this paper
• Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of Plasmodium falciparum

  2021cites this paper
• The power and promise of genetic mapping from Plasmodium falciparum crosses utilizing human liver-chimeric mice

  2021cites this paper
• A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational Repression.

  2021cites this paper
• The power and promise of genetic mapping from Plasmodium falciparum crosses utilizing human liver-chimeric mice

  2021cites this paper
• Prevalence of Sickle Cell Anemia in Association of Plasmodium falciparum from Rajnandgaon, India

  2021cites this paper
• The transmission-blocking effects antimalarial drugs revisited: mosquito fitness costs and sporontocidal effects of artesunate and sulfadoxine-pyrimethamine

  2020cites this paper
• Antimalarial drugs impact chemical messenger secretion by blood platelets

  2020cites this paper
• Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds

  2020cites this paper
• IN SILICO ANTIMALARIAL TARGET SELECTION CONSERVED IN FOUR PLASMODIUM SPECIES

  2020cites this paper
• Evaluación de la actividad antiplasmodial de las partes aéreas de plantas colectadas en Colombia

  2020cites this paper
• Efficacy of artemisinin–lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya

  2020cites this paper
• Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID‐19

  2020influential citation
• Assessing the polymorphism of DHFR gene from Plasmodium falciparum in the south of Cte dIvoire

  2020cites this paper
• Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome

  2020cites this paper
• Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

  2020cites this paper
• Proof of concept: used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014–2017

  2019cites this paper
• Antiplasmodial constituents in the minor alkaloid groups of the Amaryllidaceae

  2019cites this paper
• QSAR and Molecular docking studies of 4-anilinoquinoline-triazine hybrids as pf-DHFR inhibitors

  2019cites this paper
• Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival.

  2019cites this paper
• Surprising variation in the outcome of two malaria genetic crosses using humanized mice: implications for genetic mapping and malaria biology

  2019cites this paper
• Therapeutic Potential of Plant Based Natural Compounds for Malaria-Recent Advances and Future Perspective

  2019cites this paper
• Antiplasmodial Lycorane Alkaloid Principles of the Plant Family Amaryllidaceae

  2019influential citation
• Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum*

  2019cites this paper
• Identification of Fis1 Interactors in Toxoplasma gondii Reveals a Novel Protein Required for Peripheral Distribution of the Mitochondrion

  2019cites this paper
• Liberia 1976 – 78

  2019cites this paper
• In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: a multicomplex-based approach

  2018cites this paper
• Past and Current Findings in Antimalarial Drug Resistance Molecular Markers in Endemic Areas of Africa

  2018cites this paper
• Investigating calcium channel blockers as antimalarials

  2018cites this paper
• Investigating the absorptive and secretory transport of selected anti-malarial drugs

  2018cites this paper
• Intravenous Human Serum Albumin (HSA)-Bound Artemether Nanoparticles for Treatment of Severe Malaria

  2018cites this paper
• Proof of concept: Malaria rapid diagnostic tests and massively parallel sequencing for surveillance of molecular markers of antimalarial resistance in Bissau, Guinea-Bissau during 2014-2017

  2018cites this paper
• Bioavailability and Pharmacokinetics of Dihydroartemisinin (DHA) and its Analogs—Mechanistic Studies on its ADME

  2018cites this paper
• Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins – biochemical and structural insights

  2018cites this paper
• Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana

  2018cites this paper
• Antiplasmodial activity and cytotoxicity, isolation of active alkaloids, and dereplication of Xylopia sericea leaves ethanol extract by UPLC‐DAD‐ESI‐MS/MS

  2018cites this paper
• Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.

  2018cites this paper
• Current scenario and future strategies to fight artemisinin resistance

  2018cites this paper
• Antimalarial Drug Discovery: Structural Insights

  2018cites this paper
• Recherche des molécules antiparasitaires à l’interface de l’ethnopharmacologie, des sciences analytiques et de la biologie

  2018influential citation
• Amodiaquine Resistance in Plasmodium Berghei is Associated with Pbcrt His95Pro Mutation, Loss of Chloroquine, Artemisinin and Primaquine Sensitivity, and High Transcript Levels of Key Transporters [Version 2; Referees: 3 Approved]

  2018cites this paper
• Identification and Validation of Novel Drug Targets for the Treatment of Plasmodium falciparum Malaria: New Insights

  2018cites this paper
• Piperaquine and Metabolites - Bioanalysis and Pharmacokinetics

  2017cites this paper
• Characterization of potential drug targeting folate transporter proteins from Eukaryotic Pathogens

  2017cites this paper
• Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia

  2017cites this paper
• University of Groningen Identification and Validation of Novel Drug Targets for the Treatment of Plasmodium falciparum Malaria Lunev,

  2017cites this paper
• Amodiaquine resistance in Plasmodium berghei is associated with PbCRT His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters

  2017cites this paper
• Acyclic Nucleoside Phosphonates Containing 9‐Deazahypoxanthine and a Five‐Membered Heterocycle as Selective Inhibitors of Plasmodial 6‐Oxopurine Phosphoribosyltransferases

  2017cites this paper
• Genome-wide characterization of folate transporter proteins of eukaryotic pathogens

  2017cites this paper
• Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976–78

  2017cites this paper
• Pharmacology and pharmacodynamics of selected antimalarials against P. falciparum gametocytes

  2017influential citation
• Mass Production of Artemisinin Using Hairy Root Cultivation of Artemisia annua in Bioreactor

  2017cites this paper
• Malaria and polypeptides of Plasmodium falciparum at the infected erythrocyte surface

  2016cites this paper
• Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach

  2016cites this paper
• Naphthoquine-induced Central Nervous System and Hepatic Vasculocentric Toxicity in the Beagle Dog

  2016cites this paper
• Stimulation and quantification of Babesia divergens gametocytogenesis

  2016cites this paper
• Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes

  2016cites this paper
• Effects of Vitamins in Augmentation of Malaria Treatment: A review

  2016cites this paper
• SAFETY AND EFFICACY OF ARTEMISININ AND ITS DERIVATIVES IN THE TREATMENT OF SEVERE P. FALCIPARUM MALARIA INFECTION: A REVIEW

  2016cites this paper
• Identification and Validation of Novel Drug Targets for the Treatment of Plasmodium falciparum Malaria: New Insights

  2016cites this paper
• The Mechanism of Binding Between the Plasmodium falciparum H-protein and Lipoate Ligase 1

  2016cites this paper
• QUIMIOTERAPIA ANTIMALÁRICA. MECANISMOS DE ACCIÓN Y POTENCIALES BLANCOS MOLECULARES / Antimalarial chemotherapy. Mechanisms of action and potential molecular targets

  2016cites this paper
• Resistance to antimalarial drugs: An endless world war against Plasmodium that we risk losing.

  2015cites this paper
• Exploring the contribution of new genetic markers of drug resistance in human malaria parasites

  2015cites this paper
• Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms

  2015cites this paper
• Molecular methods in malaria control in the era of pre-elimination

  2015influential citation
• Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases.

  2015cites this paper
• eview nti-malarials are anti-cancers and vice versa – One arrow two parrows hanakya

  2015cites this paper
• Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.

  2015cites this paper
• Anti-malarials are anti-cancers and vice versa - one arrow two sparrows.

  2015cites this paper
• Investigating the Potential of Primary Sulfonamides as Antimalarial Drug Leads

  2015cites this paper
• Model Studies on Peroxidic Glutathione Transferase (GST) Inhibitors: C5‐Methylated 1,2,4‐Trioxanes with C6‐Acrylate Side Chains

  2015cites this paper
• Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles.

  2015cites this paper
• Folate binding protein—Outlook for drug delivery applications

  2015cites this paper
• Investigations into phosphodieterases as targets for antimalarial drug discovery

  2015influential citation
• Vitamin B6-Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?

  2014cites this paper
• Plasmodium Drug Targets Outside the Genetic Control of the Parasite

  2014cites this paper
• Blood schizontocidal and gametocytocidal activity of 3-hydroxy-N'-arylidenepropanehydrazonamides: a new class of antiplasmodial compounds.

  2014cites this paper
• Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions

  2014cites this paper
• Inhibition of the histone deacetylase family as a drug target in the human malaria parasite, plasmodium falciparum

  2014cites this paper
• Aspects of molecular markers in drug resistant malaria

  2014cites this paper
• Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race.

  2014cites this paper
• Implicações estruturais de mutantes da piridoxal quinase de Plasmodium falciparum

  2014cites this paper
• Novel conjugated quinoline-indoles compromise Plasmodium falciparum mitochondrial function and show promising antimalarial activity.

  2013cites this paper
• Targeted inhibition of the Plasmodium falciparum Vitamin B6 producing enzyme Pdx1 and the biochemical and functional consequences thereof

  2013cites this paper
• Identification of Biochemically Distinct Properties of the Small Ubiquitin-related Modifier (SUMO) Conjugation Pathway in Plasmodium falciparum*

  2013cites this paper